±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 545  |  »Ø¸´: 2

left_left

гæ (³õÈëÎÄ̳)

[½»Á÷] ÌÀɭ·͸ÕÐÉúÎïѧ¡¢Ò½Ñ§ÁìÓòʵϰÉú

¾ßÌ幤×÷µØµã:
±±¾©º£µí
н½ð:
ÐÐÒµÄÚÖÐÉϱê×¼
ѧÀúºÍÑо¿·½Ïò:
ÉúÎïѧ¡¢Ò½Ñ§¡¢Ò©Ñ§
ÕÐÆ¸¸Úλ:
ʵϰÉú
¹«Ë¾Ãû³Æ:
ÌÀɭ·͸
¹«Ë¾ÍøÖ·:
www.thomsonreuters.com

ÌÀɭ·͸ÕÐҩѧ/ÉúÎïѧÁìÓòʵϰÉú

(˵Ã÷£º´ËʵϰÓÉÃÀ¹úͬÊÂÖ±½ÓÃæÊÔ£¬ÇëͬѧÃÇ·¢Ó¢ÎļòÀú²¢ÓÃÓ¢ÎÄÊéдÓʼþÄÚÈÝ)

ÒªÇó£º
        ÖÆÒ©Ñ§¡¢Ò©Àíѧ¡¢¼°Ïà¹ØÉúÃü¿ÆÑ§×¨ÒµµÄÑо¿Éú¡£
        Äܹ»ÔÚ2011Äê1,2,3Ô£¬Ã¿Öܹ¤×÷4ÌìÒÔÉÏ¡££¨´º½Ú¹«ÐÝÈÕ7Ìì²»ÒªÇó£©
        Äܹ»¶ÔÏà¹Ø¼¼ÊõÎĵµÖÐÒëÓ¢£¬ÓÅÐã·­ÒëÄÜÁ¦¡£Äܹ»¼òÃ÷µÄ¶ÔÄÚÈÝ×÷¸ÅÄî×Ü½á£¬ÖØÊÓϸ½Ú¡£
        ÊìϤºÍÀí½âÒ©Îï²úÆ·²ÄÁÏ¡¢¹«Ë¾ÐÂΟ塢ÁÙ´²ÊÔÑ鱨¸æÄÚÈÝ¡£
        ÊìÁ·°ì¹«Èí¼þ£¬ÍøÂçä¯ÀÀ¡¢MS OfficeµÈ¡£

¹¤×÷ÄÚÈÝ£º
        ÍøÂç¼ìË÷ÔĶÁÖÐÎÄÄÚÈÝ£¬Éæ¼°Oncology, CNS (Alzheimer¡¯s Disease; Schizophrenia; Depression) and Cardiovascular/Metabolic (diabetes, hypertension, thrombosis) ÖÎÁÆÁìÓòµÄÒ©Î↑·¢¡¢ºÏ×÷ÐÅÏ¢¡£¶ÔÐÅÏ¢½øÐÐÊÕ¼¯ÕûÀí£¬×ܽá»ã±¨£¬°üÀ¨ÊÓÐèÒª·­Òë³ÉÓ¢ÎÄ¡£
        Ö±½Ó»ã±¨¸øÃÀ¹úµÄÄÚÈݱ༭²¿ÃÅ¡£


Intern Opening for Pharmacy/Life Science graduate student at Thomson Reuters

Requirement:
        Graduate student in Pharmacy, Pharmacology, Pharmaceutics, or allied life science field.
        Ability to read technical documents in Chinese and translate the information to English. Must have high level reading comprehension and writing skills.
        Familiarity with reading and understanding information concerning pharmaceutical products, company press releases and clinical trial reports.
        Must have the ability to summarize concepts concisely.
        Detail oriented
        Familiarity with common computer software (Internet Explorer or similar web browser; Excel; MS Word; or other software)

Responsibilities:
        Search Chinese pharmaceutical company websites and SFDA website to identify companies who are developing or have developed drugs in the therapy areas of Oncology, CNS (Alzheimer¡¯s Disease; Schizophrenia; Depression) and Cardiovascular/Metabolic (diabetes, hypertension, thrombosis).
        Search Chinese company websites for press releases regarding partnering/deals involving Chinese companies and global pharmaceutical companies.
        Save relevant documents in Word with website references and enter information into Excel spreadsheet.
        Report to editorial manager in USA to ensure project milestones are being met.

ÓÐÐËȤµÄͬѧÇëÖ±½Ó½«Ó¢ÎļòÀúºÍEmail·¢µ½£ºgeraldine.liberti@thomsonreuters.com
Please send email and resume in English to geraldine.liberti@thomsonreuters.com .

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
Сľ³æ(ɳ·¢+1£¬½ð±Ò+0.5):¹§Ï²ÇÀ¸öɳ·¢£¬ÔÙ¸ø¸öºì°ü
лл·ÖÏí
2Â¥2011-01-10 11:53:21
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¡ï
Сľ³æ(½ð±Ò+0.2):ÇÀÁ˸öС°åµÊ£¬¸ø¸öºì°ü
лл·ÖÏí
3Â¥2011-01-10 14:14:23
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ left_left µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +9 Ò»ÑùYWY 2026-04-02 9/450 2026-04-03 09:20 by tigowl
[¿¼ÑÐ] µ÷¼Á +3 osbbx 2026-04-02 3/150 2026-04-03 07:47 by cc8418
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] Çóµ÷¼Á +5 Ë·Ë·»° 2026-04-02 6/300 2026-04-02 22:02 by barlinike
[¿¼ÑÐ] 071000ÉúÎïѧµ÷¼Á +7 ÖªÕÑÂû 2026-04-02 7/350 2026-04-02 21:47 by dongzh2009
[¿¼ÑÐ] ѧ˶»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧ320+Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-04-02 8/400 2026-04-02 14:12 by oooqiao
[¿¼ÑÐ] 283Çóµ÷¼Á +3 jiouuu 2026-04-02 4/200 2026-04-02 14:08 by ßÕßÕßÕßÉßÉßÉ
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á290·Ö +5 1314Åõ»¨ 2026-04-02 8/400 2026-04-02 13:16 by ÇÇßÕßÕßÕ
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +19 ³ÌÇçÖ® 2026-04-01 23/1150 2026-04-02 11:59 by ³ÌÇçÖ®
[¿¼ÑÐ] 385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á +6 qf626 2026-04-01 6/300 2026-04-02 10:39 by guoweigw
[¿¼ÑÐ] °²È«¹¤³Ì 285 Çóµ÷¼Á +3 Xinyu56 2026-04-01 4/200 2026-04-01 21:50 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] 266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á +10 ÍÛºôºßºôºß 2026-04-01 11/550 2026-04-01 21:48 by chyhaha
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷°²½»´ó²ÄÁÏѧ˶£¨Ó¢Ò»Êý¶þ£©347£¬Çóµ÷¼Áµ½¸ß·Ö×Ó/²ÄÁÏÏà¹Ø×¨Òµ +7 zju51 2026-03-31 9/450 2026-04-01 19:35 by CFQZAFU
[¿¼ÑÐ] 085600£¬321·ÖÇóµ÷¼Á +13 ´ó²öС×Ó 2026-03-31 13/650 2026-04-01 12:35 by chemdavid
[¿¼ÑÐ] ¿¼ÑÐÉúÎïÓëÒ½Ò©µ÷¼Á +7 Ìúº©º©123425 2026-03-31 7/350 2026-04-01 08:45 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó320»¯Ñ§¹¤³ÌÓë¼¼Êõѧ˶Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-03-30 8/400 2026-03-31 08:53 by lbsjt
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ²ÄÁÏÇóµ÷¼Á +6 Gymno 2026-03-30 6/300 2026-03-31 07:26 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] µ÷¼Á +4 GK72 2026-03-30 4/200 2026-03-30 20:32 by dick_runner
[¿¼ÑÐ] 328Çóµ÷¼Á +8 àŵεĻù±¾¶¼ 2026-03-27 8/400 2026-03-30 17:20 by Wang200018
[¿¼ÑÐ] µ÷¼Á¿¼ÑÐ +3 Íõ½ÜÒ» 2026-03-29 3/150 2026-03-29 08:09 by fmesaito
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û